ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS



The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.



 Key Statistics


Email: contactus@themedco.com
Ownership: Public

Web Site: The Medicines Company
Employees: 500+
Symbol: MDCO
 





Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient

Alnylam 





 Company News
The Medicines Company (MDCO) Release: Independent Research Confirms Reduction In Mortality And Bleeding Associated With Bivalirudin In High-Risk Acute Coronary Syndrome Patients Undergoing PCI 3/17/2015 11:19:22 AM
The Medicines Company (MDCO) Announces Participation At 2015 American College of Cardiology Scientific Sessions In San Diego 3/11/2015 10:39:36 AM
The Medicines Company (MDCO) To Participate In Cowen and Company 35th Annual Health Care Conference 3/2/2015 10:25:58 AM
The Medicines Company (MDCO) To Participate In 2015 RBC Capital Markets' Global Healthcare Conference 2/23/2015 10:50:24 AM
The Medicines Company (MDCO) Will See Dynamic 2015, As Trials, Approvals Gain: Citi 2/20/2015 4:08:17 PM
The Medicines Company (MDCO) Reports Fourth Quarter And Full Year 2014 Financial Results 2/18/2015 1:51:56 PM
The Medicines Company (MDCO) To Participate In Leerink Global Healthcare Conference 2/5/2015 11:37:21 AM
The Medicines Company (MDCO) Acquires Annovation Biopharma, Inc. 2/4/2015 8:16:30 AM
The Medicines Company (MDCO) Receives CHMP Positive Opinions For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) And RAPLIXA™ (sealant powder) 1/23/2015 9:10:02 AM
The Medicines Company (MDCO) Prices $350 Million Of Convertible Notes 1/8/2015 1:56:25 PM
12345678910...